Why cancer medicines are and continue to be vulnerable to drug shortages
Quality Matters
OCTOBER 24, 2023
Analysis leveraging USP’s Medicine Supply Map suggests many of the essential cancer medicines have inherently vulnerable supply chains and are at greater risk for shortage compared to other generic medicines. The closer the risk score is to 100%, the greater the risk for that drug to be in shortage in the next 12 months.
52 
Let's personalize your content